High-dose Cephalexin for Cellulitis (HI-DOCC)

Cellulitis is a common condition diagnosed and managed in the ED that carries significant burden on healthcare systems globally. Cellulitis is the 8th most common reason patients present to an ED in Canada. Among middle-aged patients (45-64 years) it is the 5th most common reason to visit an ED. This disease is responsible for significant healthcare system burden due to high hospitalization rates and subsequent costs. The Investigators conducted a health records review at two large urban EDs in Ottawa, and found that 29.6% of patients with cellulitis are admitted to hospital. In a separate study, The investigators found that the mean cost of care to hospitalize cellulitis patients for IV antibiotics was $10,145 CDN.

NCT Number	NCT05852262
Lead Sponsor	Ottawa Hospital Research Institute Collaborators: Network of Canadian Emergency Researchers (NCER), The Ottawa Hospital Academic Medical Association
Conditions	Cellulitis
Enrollment	454 participants
Start Date	2023-08-30
Primary Completion	2026-04-05 (estimated)
Study Completion	2026-04-05 (estimated)
Updated on ClinicalTrials.gov	2026-08-03